相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic polypharmacology: A new frontier for epi-drug discovery
Daniela Tomaselli et al.
MEDICINAL RESEARCH REVIEWS (2020)
Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
Hsiang-chi Tseng et al.
NATURE COMMUNICATIONS (2020)
Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy
Zigao Yuan et al.
BIOORGANIC CHEMISTRY (2019)
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer
Giulia Stazi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Cristina Segovia et al.
NATURE MEDICINE (2019)
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
Obdulia Rabal et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors
Obdulia Rabal et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy
Yong Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation
Nadja Blagitko-Dorfs et al.
LEUKEMIA (2019)
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
Obdulia Rabal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces
Obdulia Rabal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
Obdulia Rabal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors
Zigao Yuan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
T. Harada et al.
LEUKEMIA (2017)
Marked for death: targeting epigenetic changes in cancer
Sophia Xiao Pfister et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San Jose-Eneriz et al.
NATURE COMMUNICATIONS (2017)
Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors
Lanlan Zang et al.
ONCOTARGET (2017)
Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia
Chengyin Min et al.
PLOS ONE (2017)
Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation
Dimitry A. Chistiakov et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
Jesus F. San-Miguel et al.
ADVANCES IN THERAPY (2016)
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease
Obdulia Rabal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Epigenetic polypharmacology: from combination therapy to multitargeted drugs
Angel R. de Lera et al.
CLINICAL EPIGENETICS (2016)
Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
Xabier Agirre et al.
GENOME RESEARCH (2015)
Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors As Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead
Josune Orbe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
Munawwar Ali Khan et al.
ONCOLOGY REPORTS (2015)
Targeting DNA Methylation with Small Molecules: What's Next? Miniperspective
Alexandre Erdmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
William N. Pappano et al.
PLOS ONE (2015)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
Christopher J. Millard et al.
MOLECULAR CELL (2013)
The future of epigenetic therapy in solid tumours-lessons from the past
Nilofer Azad et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
Ken Maes et al.
Cancers (2013)
Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
Matthias G. J. Baud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities
Raquel Pereira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation
Jikui Song et al.
SCIENCE (2012)
Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimer's Disease
M. Cuadrado-Tejedor et al.
CURRENT MEDICINAL CHEMISTRY (2011)
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Masoud Vedadi et al.
NATURE CHEMICAL BIOLOGY (2011)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Peter Atadja
CANCER LETTERS (2009)
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase
Stefan Kubicek et al.
MOLECULAR CELL (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Psammaplins from the sponge Pseudoceratina purpurea:: Inhibition of both histone deacetylase and DNA methyltransferase
IC Piña et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
分享论文
